Different cancers have different tumor markers for the differential diagnosing of visceral malignancy; such as prostate specific antigen (PSA) for prostate cancer (4, 5), carcinoembryonic antigen (CEA) for colon cancer (6), and vanillylmandelic acid (VMA) for pheochromocytoma (7). This evidence concerns the gene CEACAM5 and pheochromocytoma.